Eloxx Pharmaceuticals, Inc. (ELOX): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2011-06-30 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest EBITDA is for the year ended 2014-06-30, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$8.80M
Year ended 2014-06-30
2010-06-30: -$4.72M2011-06-30: -$7.78M2012-06-30: -$5.15M2013-06-30: -$4.36M2014-06-30: -$8.80M-$8.80M
2010-06-30 EBITDA (USD) 2014-06-30
Period endedEBITDAChange YoYSource filing
2014-06-30-$8.80Mn/m2016-10-13, From 2013-07-01
2013-06-30-$4.36Mn/m2015-10-09, From 2012-07-01
2012-06-30-$5.15Mn/m2014-09-29, From 2011-07-01
2011-06-30-$7.78Mn/c2013-09-11, From 2010-07-01
2010-06-30-$4.72Mn/a2012-10-26, From 2009-07-01